Partners plans to support the animal health compounding pharmacy with new product development, increased production at the company’s FDA-registered 503B Outsourcing Facility, among other things.
To read this article, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
New to PE Hub?
Register now to read this article and more for free.
